Neogenomics (NEO) Interest & Investment Income (2013 - 2026)

Neogenomics (NEO) has 10 years of Interest & Investment Income data on file, last reported at $1.2 million in Q2 2026.

• Quarterly Interest & Investment Income fell 46.35% year-over-year to $1.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.6 million (down 51.17% YoY) and the FY2025 annual result came in at $9.1 million, down 50.78% from the prior year.
• Interest & Investment Income eased to $1.2 million in Q2 2026, from $1.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.8 million in Q4 2023 to a low of -$2.4 million in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.2 million in 2026 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 1381.88% — and 2026, when it soared 748.67%.
• Tracing NEO's Interest & Investment Income over 5 years: stood at -$1.0 million in 2022, then surged by 562.75% to $4.8 million in 2023, then fell by 10.67% to $4.3 million in 2024, then tumbled by 64.81% to $1.5 million in 2025, then decreased by 20.29% to $1.2 million in 2026.
• The last three Interest & Investment Income figures came in at $1.2 million (Q2 2026), $1.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.